In its third quarter results of 2024, pharmaceutical giant GSK confirmed it would pay a quarterly dividend of 15 pence. However, Morningstar analyst Christopher Johnson says he believes that GSK’s ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

WASHINGTON — Pharmaceutical industry giant GSK plans to depart the biotechnology industry’s largest trade group, the ...

GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug ...

Chronic HBV kills around 900,000 people every year, said GSK. The company's head of development, Chris Corsico, said that bepirovirsen has the potential to become a "transformative" therapy for ...

GSK reiterated its full-year guidance after its new HIV and cancer treatments lifted profit ahead of analysts’ expectations ...

GSK has stopped (PDF) development of one of the lead programs from its $2.1 billi | GSK has stopped development of one of the lead programs from its $2.1 billion Affinivax takeover, axing a phase 2 ...

Preclinical studies have already shown “rapid, deep B cell depletion both in the bloodstream and in tissues which could lead to more durable responses in patients,” GSK pointed out. If successful, it ...

GSK (GSK) plc and Chimagen Biosciences, a privately held biotechnology company, announced an agreement for GSK to acquire CMG1A46, a ...

FIRMS big and small have slammed the Chancellor for saddling them with extra costs in her Budget. They say Rachel Reeves’ ...

The Tampa Bay Buccaneers lost star wide receiver Chris Godwin to a likely season-ending ankle injury in the final minute of their 41-31 Week 7 loss to the Baltimore Ravens. Godwin suffered a ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is ...